Report on the safety, immunogenicity and immuno-efficacy of Pvs25-IMX313 in Matrix-M1 adjuvant

Summary
Report on the safety immunogenicity and immunoefficacy of Pvs25IMX313 in MatrixM1 adjuvant for transmissionblocking vaccine clinical trial
More information & hyperlinks
Web resources: https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e5f837d992&appId=PPGMS
Search
Search on Google
Search on Bing
Search on DuckDuckGo
Associated projects
Organisations
  • Not specified
Powered by Chris Decubber BV